Literature DB >> 15078671

Prevalence of open-angle glaucoma among adults in the United States.

David S Friedman1, Roger C W Wolfs, Benita J O'Colmain, Barbara E Klein, Hugh R Taylor, Shelia West, M Cristina Leske, Paul Mitchell, Nathan Congdon, John Kempen.   

Abstract

OBJECTIVE: To estimate the prevalence and distribution of open-angle glaucoma (OAG) in the United States by age, race/ethnicity, and gender.
METHODS: Summary prevalence estimates of OAG were prepared separately for black, Hispanic, and white subjects in 5-year age intervals starting at 40 years. The estimated rates were based on a meta-analysis of recent population-based studies in the United States, Australia, and Europe. These rates were applied to 2000 US census data and to projected US population figures for 2020 to estimate the number of the US population with OAG.
RESULTS: The overall prevalence of OAG in the US population 40 years and older is estimated to be 1.86% (95% confidence interval, 1.75%-1.96%), with 1.57 million white and 398 000 black persons affected. After applying race-, age-, and gender-specific rates to the US population as determined in the 2000 US census, we estimated that OAG affects 2.22 million US citizens. Owing to the rapidly aging population, the number with OAG will increase by 50% to 3.36 million in 2020. Black subjects had almost 3 times the age-adjusted prevalence of glaucoma than white subjects.
CONCLUSIONS: Open-angle glaucoma affects more than 2 million individuals in the United States. Owing to the rapid aging of the US population, this number will increase to more than 3 million by 2020.

Entities:  

Mesh:

Year:  2004        PMID: 15078671      PMCID: PMC2798086          DOI: 10.1001/archopht.122.4.532

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  30 in total

1.  Practice implications of the Glaucoma Laser Trial.

Authors:  P R Lichter
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

2.  Prevalence of glaucoma in a rural East African population.

Authors:  R R Buhrmann; H A Quigley; Y Barron; S K West; M S Oliva; B B Mmbaga
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

3.  National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings.

Authors:  R P Mason; O Kosoko; M R Wilson; J F Martone; C L Cowan; J C Gear; D Ross-Degnan
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

4.  Mobility performance in glaucoma.

Authors:  K A Turano; G S Rubin; H A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-11       Impact factor: 4.799

5.  Ocular beta-blockers and systemic effects.

Authors:  F T Fraunfelder
Journal:  Arch Intern Med       Date:  1986-06

6.  Cardiac effects of topical timolol.

Authors:  N A Britman
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

7.  The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district.

Authors:  P J Foster; F T Oen; D Machin; T P Ng; J G Devereux; G J Johnson; P T Khaw; S K Seah
Journal:  Arch Ophthalmol       Date:  2000-08

8.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

9.  Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study.

Authors:  L Dandona; R Dandona; P Mandal; M Srinivas; R K John; C A McCarty; G N Rao
Journal:  Ophthalmology       Date:  2000-09       Impact factor: 12.079

10.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10
View more
  308 in total

1.  African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes.

Authors:  Lyne Racette; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill; Sonia Jain; Lida M Becerra; Felipe A Medeiros; Christopher Bowd; Robert N Weinreb; Catherine Boden; Pamela A Sample
Journal:  Arch Ophthalmol       Date:  2010-05

2.  Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.

Authors:  Steven M Kymes; Michael R Plotzke; Michael A Kass; Michael V Boland; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2010-05

3.  Biomechanical changes in the sclera of monkey eyes exposed to chronic IOP elevations.

Authors:  Michaël J A Girard; J-K Francis Suh; Michael Bottlang; Claude F Burgoyne; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

4.  What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities.

Authors:  Tianjing Li; S Swaroop Vedula; Roberta Scherer; Kay Dickersin
Journal:  Ann Intern Med       Date:  2012-03-06       Impact factor: 25.391

5.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

6.  Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study.

Authors:  David C Musch; Takayuki Shimizu; Leslie M Niziol; Brenda W Gillespie; L Frank Cashwell; Paul R Lichter
Journal:  Br J Ophthalmol       Date:  2012-07-06       Impact factor: 4.638

7.  Glaucoma patient expression of medication problems and nonadherence.

Authors:  Catherine Slota; Robyn Sayner; Michelle Vitko; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Betsy Sleath
Journal:  Optom Vis Sci       Date:  2015-05       Impact factor: 1.973

8.  Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient.

Authors:  Brian C Samuels; Nathan M Hammes; Philip L Johnson; Anantha Shekhar; Stuart J McKinnon; R Rand Allingham
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-23       Impact factor: 4.799

9.  Integrating Patient Education Into the Glaucoma Clinical Encounter: A Lean Analysis.

Authors:  Paula A Newman-Casey; John A Musser; Leslie M Niziol; Michele M Heisler; Shivani S Kamat; Manjool M Shah; Nish Patel; Amy M Cohn
Journal:  J Glaucoma       Date:  2019-05       Impact factor: 2.503

10.  Integrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis).

Authors:  John C Morrison
Journal:  Trans Am Ophthalmol Soc       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.